Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice
JournalJournal of Neuroscience Research
PublisherJohn Wiley and Sons Inc.
MetadataShow full item record
AbstractNicotinamide adenine dinucleotide (NAD+) is a central signaling molecule and enzyme cofactor that is involved in a variety of fundamental biological processes. NAD+ levels decline with age, neurodegenerative conditions, acute brain injury, and in obesity or diabetes. Loss of NAD+ results in impaired mitochondrial and cellular functions. Administration of NAD+ precursor, nicotinamide mononucleotide (NMN), has shown to improve mitochondrial bioenergetics, reverse age‐associated physiological decline, and inhibit postischemic NAD+ degradation and cellular death. In this study, we identified a novel link between NAD+ metabolism and mitochondrial dynamics. A single dose (62.5 mg/kg) of NMN, administered to male mice, increases hippocampal mitochondria NAD+ pools for up to 24 hr posttreatment and drives a sirtuin 3 (SIRT3)‐mediated global decrease in mitochondrial protein acetylation. This results in a reduction of hippocampal reactive oxygen species levels via SIRT3‐driven deacetylation of mitochondrial manganese superoxide dismutase. Consequently, mitochondria in neurons become less fragmented due to lower interaction of phosphorylated fission protein, dynamin‐related protein 1 (pDrp1 [S616]), with mitochondria. In conclusion, manipulation of mitochondrial NAD+ levels by NMN results in metabolic changes that protect mitochondria against reactive oxygen species and excessive fragmentation, offering therapeutic approaches for pathophysiologic stress conditions.
SponsorsThis work was supported by U.S. Veterans Affairs Merit grant BX000917 to TK.
nicotinamide adenine dinucleotide
ROS (reactive oxygen species)
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85060355005&doi=10.1002%2fjnr.24397&partnerID=40&md5=1687494c4cab8a2e4678942113ff7cbe; http://hdl.handle.net/10713/10191
- NAD<sup>+</sup> precursor modulates post-ischemic mitochondrial fragmentation and reactive oxygen species generation via SIRT3 dependent mechanisms.
- Authors: Klimova N, Fearnow A, Long A, Kristian T
- Issue date: 2020 Mar
- Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure.
- Authors: Zhang R, Shen Y, Zhou L, Sangwung P, Fujioka H, Zhang L, Liao X
- Issue date: 2017 Nov
- Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
- Authors: Wang X, Hu X, Yang Y, Takata T, Sakurai T
- Issue date: 2016 Jul 15
- Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
- Authors: Long AN, Owens K, Schlappal AE, Kristian T, Fishman PS, Schuh RA
- Issue date: 2015 Mar 1
- Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons.
- Authors: Chandrasekaran K, Choi J, Arvas MI, Salimian M, Singh S, Xu S, Gullapalli RP, Kristian T, Russell JW
- Issue date: 2020 May 26